| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4862218
Max Phase: Preclinical
Molecular Formula: C25H51NO2
Molecular Weight: 397.69
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CCCCCCCCCCCCCC[C@H](O)[C@H](C)NC(=O)CCCCCCC
Standard InChI: InChI=1S/C25H51NO2/c1-4-6-8-10-11-12-13-14-15-16-18-19-21-24(27)23(3)26-25(28)22-20-17-9-7-5-2/h23-24,27H,4-22H2,1-3H3,(H,26,28)/t23-,24-/m0/s1
Standard InChI Key: LQEKXKVEOUCASI-ZEQRLZLVSA-N
Associated Targets(Human)
Acid ceramidase 411 Activities
Associated Targets(non-human)
Alkaline ceramidase 3 54 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 397.69 | Molecular Weight (Monoisotopic): 397.3920 | AlogP: 7.30 | #Rotatable Bonds: 21 |
| Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.12 | CX LogD: 8.12 |
| Aromatic Rings: 0 | Heavy Atoms: 28 | QED Weighted: 0.20 | Np Likeness Score: 0.38 |
References
| 1. Bielsa N, Casasampere M, Aseeri M, Casas J, Delgado A, Abad JL, Fabriàs G.. (2021) Discovery of deoxyceramide analogs as highly selective ACER3 inhibitors in live cells., 216 [PMID:33677352] [10.1016/j.ejmech.2021.113296] |
Source
Source(1):